A look, taste and aroma of the coffee grown in Uganda leave a desire to know how the place looks like. The truth behind that coffee is that the aroma masks away the hardships brought about by the devastating effect of climate change. Today, changes in the environment have contributed to a sharp decline in the productivity of the cash crop. Rising temperatures exposes the coffee beans to pest and diseases. In Uganda, most of the coffee produced comes from small-scale farmers who have little or no access to irrigation water and modern farming conveniences. A fifth of the country’s population depends on the crop for income as it’s among the most valuable industry in the country. According to an economic analysis conducted by the Ugandan government, changes in the climate will reduce the countries production by half by the year 2050.
The country’s production is minimal compared to the world’s overall production. Therefore, a change in its production will have little or no effect on the prices. However, the reality is that people in Uganda will suffer a major setback in revenue generation. Photos taken are just but a window showing the devastating effects that climate change causes for the people of Uganda. Farmers depending on the crop to put food on the table and pay fees for their children are between a rock and a hard place. Therefore, advocating for measures to mitigate climate change is important as millions of lives depend on it.
Clay Siegall founded Seattle Genetics with the aim of finding methods of suppressing cancer. It was at such a time when treating cancer patients involved subjecting them to chemotherapies. The methods didn’t differentiate between cancer cells and healthy living cells, and eventually, they left the immune system worn out and prone to other diseases. Clay Siegall sought to bring new methods of cancer treatment and improve the lives of people living with cancer. Therefore, he set out to develop therapies that satisfied a lot of unmet needs in the cancer treatment.
Clay spearheads all research activities in Seattle Genetics. He has led the company to its global position. Under his leadership, the organization has developed ADCs for the treatment of cancer and secured more than $ 1.2 billion in funding.